← Eichor
Condition: Pulmonary Tuberculosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pulmonary Tuberculosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic F
Phase N/A · 1 location(s) · Ospedale San Raffaele · NCT06413459ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
Phase 1 · 4 location(s) · Quratis Inc. · NCT06714513Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 2/Phase 3 · 6 location(s) · University of California, San Francisco · NCT0644100618F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07077213Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure
Phase N/A · 2 location(s) · Research Center Borstel · NCT07369414Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Phase 2 · 11 location(s) · University College, London · NCT06114628Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Phase 3 · 8 location(s) · Kaohsiung Veterans General Hospital. · NCT06727864Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline
Phase 2 · 2 location(s) · Makerere University · NCT06477185Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NA · 2 location(s) · Johns Hopkins University · NCT07164742Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of M
Phase 2 · 11 location(s) · Janssen Research & Development, LLC · NCT02354014TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease
Phase N/A · 1 location(s) · Universitas Padjadjaran · NCT07451899Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Phase 2 · 29 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06192160Respiratory Health and Wellbeing Post Pulmonary Tuberculosis
Phase N/A · 1 location(s) · Liverpool School of Tropical Medicine · NCT07178860Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB
Phase 2 · 11 location(s) · Global Alliance for TB Drug Development · NCT07672405A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Phase 2/Phase 3 · 1 location(s) · University of Cape Town · NCT04147286Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Phase 2 · 13 location(s) · Gates Medical Research Institute · NCT07525427Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Phase N/A · 1 location(s) · ChromX Health · NCT06528418ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
Phase 2 · 3 location(s) · Obafemi Awolowo University Teaching Hospital · NCT07303699Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
Phase 4 · 6 location(s) · Bin Cao · NCT07213765Shortened Regimen for Drug-susceptible TB in Children
Phase 3 · 9 location(s) · Johns Hopkins University · NCT06253715Seoul National University Airway Registry
Phase N/A · 3 location(s) · Seoul National University Hospital · NCT02527486A PAN-USR TB Multi-Center Trial
Phase 3 · 3 location(s) · Shenzhen Third People's Hospital · NCT06905522Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active
Phase N/A · 3 location(s) · University of Stellenbosch · NCT04700579Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
Phase 2/Phase 3 · 6 location(s) · Huashan Hospital · NCT05401071A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
NA · 1 location(s) · The Aurum Institute NPC · NCT06909799Tuberculosis Cohort Avicenne Hospital
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05539014Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
Phase 2 · 1 location(s) · Thirty Respiratory Limited · NCT07073638
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.